Is GHDX a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

569 people get GHDX articles and Market Currents by email alert.

Get email alerts on GHDX »

HEADLINES:

6 Ways You Can Profit From Molecular Diagnostics
Cory Renauer • Wed, May 22 • 12 Comments
Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting

PR Newswire (Tue, 8:00AM)
Genomic Health's New Prostate Test May Extend The Stock's Upward Climb
Amy Baldwin • Wed, May 15
Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) Diagnosis

PR Newswire (May 10, 2013)
Companies Fighting Against Prostate Cancer
Equity Options Guru • Thu, May 9 • 10 Comments
Genomic Health's CEO Reviews Positive Clinical Validation and Development of the Oncotype DX Prostate Cancer Test (Transcript)
Thu, May 9
Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments

PR Newswire (May 8, 2013)
Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments

PR Newswire (May 8, 2013)
Genomic Health to Present at Bank of America Merrill Lynch Health Care Conference

PR Newswire (May 7, 2013)
Genomic Health Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 2
Genomic Health and ECOG-ACRIN Cancer Research Group Announce Publication of Positive DCIS Validation Study in the Journal of the National Cancer Institute

PR Newswire (May 2, 2013)
Genomic Health Announces First Quarter 2013 Financial Results and Business Progress

PR Newswire (May 2, 2013)
Genomic Health Announces Investor Webcast and Conference Call to Review Positive Clinical Validation and Development of the Oncotype DX® Prostate Cancer Test on Wednesday, May 8, 2013

PR Newswire (May 1, 2013)
Insiders Are Buying These 9 Environmentally Conscious Stocks
Kapitall • Fri, Apr 26
Genomic Health to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 2, 2013

PR Newswire (Apr 25, 2013)
Genomic Health Announces Publication of Second Positive Validation of Oncotype DX Colon Cancer Test Confirming Its Value Beyond Conventional Markers

PR Newswire (Apr 17, 2013)
Genomic Health to Address One of the Most Significant Needs in Men's Health with the Oncotype DX® Prostate Cancer Test

PR Newswire (Apr 3, 2013)
Genomic Health Presents Twenty Two International Studies Demonstrating Worldwide Adoption and Value of Oncotype DX® Breast Cancer Test

PR Newswire (Mar 15, 2013)
Genomic Health Announces Positive Results from Large Study of Oncotype DX® to Quantify Risk of Loco-Regional Recurrence in Node-positive Breast Cancer Patients and Acceptance of Oncotype DX DCIS Validation Study for Publication

PR Newswire (Mar 13, 2013)
Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology

PR Newswire (Feb 25, 2013)

To learn more about Seeking Alpha Pro, click here.

Genomic Health's New Prostate Test May Extend The Stock's Upward Climb
Amy Baldwin • Wed, May 15
Genomic Health: Possible Takeover Candidate?
Jason Chew • Wed, Jun 9, 2010 • 3 Comments
Good News for Genomic Health
Zacks Investment Research • Tue, Sep 8, 2009
Genomic Health Inc. Needs Label Expansion
Zacks Investment Research • Fri, Jun 26, 2009
The Short Case on Genomic Health
Kevin McNamara • Mon, Feb 12, 2007 • 2 Comments
Agendia Gets FDA Approval For Breast Cancer Test
Centient Biotech Investor • Thu, Feb 8, 2007

6 Ways You Can Profit From Molecular Diagnostics
Cory Renauer • Wed, May 22 • 12 Comments
Companies Fighting Against Prostate Cancer
Equity Options Guru • Thu, May 9 • 10 Comments
Insiders Are Buying These 9 Environmentally Conscious Stocks
Kapitall • Fri, Apr 26
Response Genetics' Competitors: Who To Watch, Who To Worry About
Bay Area Biotech • Fri, Feb 8 • 7 Comments
The Business Of Cancer
Marc Lichtenfeld • Wed, Feb 6 • 3 Comments
3 High-Growth Healthcare Stocks With Bearish Short Trends
Kapitall • Wed, Jan 16
3 Stocks With Recent Intensive Insider Selling
Markus Aarnio • Mon, Jan 14 • 1 Comment
Creative Destruction And The Pharmaceutical Industry
Ron Sommer • Sun, Jan 6 • 14 Comments
Hedge Funds Are Buying These 5 Healthcare Stocks With Heavy Short Covering
Kapitall • Fri, Nov 30, 2012
Insiders Love These 2 High Growth Stocks
Kapitall • Wed, Nov 21, 2012
World Demographics: Embracing The Gracious Aging World
Nick Chiu • Fri, Nov 16, 2012 • 15 Comments
5 Healthcare Companies With Recent Insider Buying
Markus Aarnio • Thu, Nov 15, 2012
Only 2 High-Growth Healthcare Stocks Are Being Bought Up By Insiders
Kapitall • Fri, Nov 2, 2012
Earnings Analysis: Quest Diagnostics Inc.
CapitalCube • Thu, Oct 18, 2012
Qiagen: Downside Priced In, CDx And Automation Upside, Undervalued Compared To Peers
Dave Westenberg • Sat, Sep 29, 2012
5 Highly Shorted Small-Caps With Strong Insider And Institutional Buying
Kapitall • Tue, Sep 18, 2012
7 High-Growth Small Caps With Minimal Debt
ZetaKap • Thu, Aug 30, 2012
For Exact Sciences, Approval May Be The Easy Part
Stephen Simpson • Thu, Aug 23, 2012 • 13 Comments
Cepheid: Awesome Company, But Overpriced
Dave Westenberg • Fri, Aug 10, 2012
Coming Wave Of Companion Diagnostics: Who's Making A Splash
Dave Westenberg • Thu, Jul 26, 2012 • 7 Comments

Genomic Health's CEO Reviews Positive Clinical Validation and Development of the Oncotype DX Prostate Cancer Test (Transcript)
Thu, May 9
Genomic Health Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 2
Genomic Health's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Feb 6 • 1 Comment
Genomic Health Management Discusses Q3 2012 Results - Earnings Call Transcript
Wed, Nov 7, 2012
Genomic Health's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Fri, Aug 10, 2012
Genomic Health, Inc. Q2 2009 Earnings Call Transcript
Tue, Aug 4, 2009
Genomic Health, Inc. Q1 2009 Earnings Call Transcript
Tue, May 5, 2009
Genomic Health, Inc. Q4 2008 Earnings Call Transcript
Tue, Feb 3, 2009
Genomic Health, Inc. Q3 2008 Earnings Call Transcript
Fri, Nov 21, 2008
Genomic Health Inc. Q2 2008 Earnings Call Transcript
Fri, Sep 5, 2008
Genomic Health Inc. Q1 2008 Earnings Call Transcript
Mon, May 26, 2008
Genomic Health Q3 2007 Earnings Call Transcript
Tue, Oct 30, 2007

Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting

PR Newswire (Tue, 8:00AM)
Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) Diagnosis

PR Newswire (May 10, 2013)
Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments

PR Newswire (May 8, 2013)
Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments

PR Newswire (May 8, 2013)
Genomic Health to Present at Bank of America Merrill Lynch Health Care Conference

PR Newswire (May 7, 2013)
Genomic Health and ECOG-ACRIN Cancer Research Group Announce Publication of Positive DCIS Validation Study in the Journal of the National Cancer Institute

PR Newswire (May 2, 2013)
Genomic Health Announces First Quarter 2013 Financial Results and Business Progress

PR Newswire (May 2, 2013)
Genomic Health Announces Investor Webcast and Conference Call to Review Positive Clinical Validation and Development of the Oncotype DX® Prostate Cancer Test on Wednesday, May 8, 2013

PR Newswire (May 1, 2013)
Genomic Health to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 2, 2013

PR Newswire (Apr 25, 2013)
Genomic Health Announces Publication of Second Positive Validation of Oncotype DX Colon Cancer Test Confirming Its Value Beyond Conventional Markers

PR Newswire (Apr 17, 2013)
Genomic Health to Address One of the Most Significant Needs in Men's Health with the Oncotype DX® Prostate Cancer Test

PR Newswire (Apr 3, 2013)
Genomic Health Presents Twenty Two International Studies Demonstrating Worldwide Adoption and Value of Oncotype DX® Breast Cancer Test

PR Newswire (Mar 15, 2013)
Genomic Health Announces Positive Results from Large Study of Oncotype DX® to Quantify Risk of Loco-Regional Recurrence in Node-positive Breast Cancer Patients and Acceptance of Oncotype DX DCIS Validation Study for Publication

PR Newswire (Mar 13, 2013)
Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology

PR Newswire (Feb 25, 2013)
Genomic Health Announces Year-End 2012 Financial Results, Provides 2013 Financial Outlook

PR Newswire (Feb 6, 2013)
Genomic Health to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, February 6, 2013

PR Newswire (Jan 30, 2013)
Genomic Health Announces New Evidence Further Demonstrating Clinical Utility and Cost-Effectiveness of Oncotype DX in Colon Cancer

PR Newswire (Jan 23, 2013)
Genomic Health to Present at the J.P. Morgan Healthcare Conference

PR Newswire (Dec 21, 2012)
Genomic Health Announces Results from Six Studies Demonstrating Unique Value of the Oncotype DX Breast Cancer Test in Early Stage Breast Cancer

PR Newswire (Dec 10, 2012)
Genomic Health Announces Presentation of Six Studies at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium

PR Newswire (Nov 28, 2012)

GHDX vs. ETF Alternatives

Company Description

Genomic Health is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. Our goal is to improve the quality of treatment decisions for cancer patients by providing individualized information to patients and their physicians... More

Sector: Healthcare

Industry: Medical Laboratories & Research

Country: United States

Jim Van Meerten
$GHDX - 100% Barchart technical buy signals - 16 new highs and up 23.90% in hte last month - Relative Strength Index 78.22%
May 3, 3:58 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Kapitall
Insiders Are Buying 9 Environmentally Conscious Stocks $AMRS $ATSG $GHDX $MNKD $ODP $PHII $TRGT $VHI $VSAT http://seekingalpha.com/a/th4l
Apr 26, 4:08 PM
Reply (1)

• !Report Abuse
View all 1 replies
vireoman: So the spraying of Afrezza into one's nose evidently doesn't contribute to global warming?
Apr 27, 12:05 AM
• !Report Abuse
Add a reply...

140 characters

ltfinger
Returning Upgrades (4/11/13): $ELLI, $FIS, $FR, $FRAN, $FSTR, $FXC, $GHDX, $GIL, $HLS, $HRL, $HRS, $HSIC, $JACK, $JBT, $JCOM, $LPS, $LUX
Apr 12, 10:32 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
7 High-Growth Small Caps With Minimal Debt http://bit.ly/S2fBxW $CSOD $CTCM $ENV $GHDX $GEOS $P $Z @ZetaKap
8/30/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Joe Springer
#biotech #pharma #stocks $VNDA $LLY $PPHM $GHDX $SCLN $AMRN $CRTX $NVS Vanda looks like a buy here: http://seekingalpha.com/a/h3pb
8/10/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Trimble Navigation (TRMB), Kinder Morgan (KMI), Generac (GNRC), Genomic Health (GHDX), & Cantel Medical (CMN) rose Monday on unusual volume.
5/21/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Dick's Sporting Goods (DKS), Genomic Health (GHDX), Radware (RDWR), (TJX), Red Robin Gourmet Burgers (RRGB) rose Tuesday on unusual volume.
5/15/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Arctic Cat (ACAT), Ormat Tech (ORA), Vertex Pharma (VRTX), Ultimate Software (ULTI), & Genomic Health (GHDX) rose Monday on unusual volume.
5/14/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Joshua Hayes
$CMC $RPTP $MGN $OWW $PKT $LTS $ANLY $CERS $HW $NTE $CFX $GHDX $ALLT $ONE $CFX $MELI $PRIM $TASR some beautiful chart patterns out there.
12/6/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Joshua Hayes
$CMC $RPTP $MGN $OWW $PKT $LTS $ANLY $CERS $HW $NTE $CFX $GHDX $ALLT $ONE $CFX $MELI $PRIM $TASR some beautiful chart patterns out there.
12/6/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Kapitall
Insiders Are Buying 9 Environmentally Conscious Stocks $AMRS $ATSG $GHDX $MNKD $ODP $PHII $TRGT $VHI $VSAT http://seekingalpha.com/a/th4l
Apr 26, 4:08 PM
Reply (1)

• !Report Abuse
View all 1 replies
vireoman: So the spraying of Afrezza into one's nose evidently doesn't contribute to global warming?
Apr 27, 12:05 AM
• !Report Abuse
Add a reply...

140 characters

GHDX Genomic Health, Inc.

GHDX

Genomic Health, Inc.